Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

NCT02399735 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Low Dose NK cells ×4 times
BIOLOGICAL: Normal Dose NK cells ×4 times
BIOLOGICAL: Normal Dose NK cells ×8 times

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University